Küleon Bioscience a drug discovery business, uses patented, AI-based technologies.
Küleon Bioscience has raised $2.0M in total funding. The most recent round was Grant. The last funding was announced in September 2025.
Küleon Bioscience's investors include National Institute on Alcohol Abuse and Alcoholism.
Küleon Bioscience is headquartered in Seattle, United States.
Küleon Bioscience a drug discovery business, uses patented, AI-based technologies.
Küleon Bioscience is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Küleon Bioscience — Funding & Investors." VCBacked, September 23, 2025, https://www.vcbacked.co/company/kleon-bioscience. Accessed October 2, 2026.
VCBacked. (2025). Küleon Bioscience — Funding & Investors. Retrieved October 2, 2026, from https://www.vcbacked.co/company/kleon-bioscience
{{cite web |title=Küleon Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/kleon-bioscience |website=VCBacked |access-date=October 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated